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Abstract 
Dietary methionine restriction (MR) leads to loss of adiposity, improved insulin sensitivity and lifespan 
extension.  The possibility that dietary MR can protect the kidney from age-associated deterioration has 
not been addressed.  Aged (10-month old) male and female mice were placed on a MR (0.172% 
methionine) or control diet (0.86% methionine) for 8-weeks and blood glucose, renal insulin signalling, 
and gene expression were assessed.  Methionine restriction lead to decreased blood glucose levels 
compared to control-fed mice, and enhanced insulin-stimulated phosphorylation of PKB/Akt and S6 in 
kidneys, indicative of improved glucose homeostasis.  Increased expression of lipogenic genes and 
downregulation of PEPCK were observed, suggesting that kidneys from MR-fed animals are more 
insulin sensitive.  Interestingly, renal gene expression of the mitochondrial uncoupling protein UCP1 
was upregulated in MR-fed animals, as were the anti-ageing and renoprotective genes Sirt1, FGF21, 
klotho, and β-klotho.  This was associated with alterations in renal histology trending towards reduced 
frequency of proximal tubule intersections containing vacuoles in mice that had been on dietary MR for 
190 days compared to control-fed mice, which exhibited a pre-diabetic status.  Our results indicate that 
dietary MR may offer potential in ameliorating the renal functional decline related to ageing and other 
disorders associated with metabolic dysfunction by enhancing renal insulin sensitivity and 
renoprotective gene expression.   
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1. Introduction 
The accumulation of visceral fat is associated with ageing and is strongly linked to the development of 
metabolic disorders including insulin resistance (1, 2). Surgical removal of visceral fat or reduction in 
adiposity by caloric restriction (CR), are effective strategies in rodents for increasing lifespan and 
enhancing insulin sensitivity (2-4).  Reducing dietary levels of the essential amino acid methionine also 
extends lifespan (5, 6).  The advantage of dietary MR is that its benefits do not require restriction of 
food intake.   
Our group has recently demonstrated that a MR diet can reverse age-induced metabolic dysfunction in 
adult mice by lipid homeostasis remodelling in the liver and white adipose tissue (WAT), and enhance 
insulin sensitivity in peripheral tissues (7).  The occurrence of age-related glucose intolerance due to 
defective insulin secretion, clearance and peripheral tissue responses to insulin, is also well documented 
(8).  Kidney function is also known to significantly decline with age with an estimated average loss of 
glomerular filtration rate (GFR) of approximately 1 millilitre per year and an increased predisposition 
to glomerulosclerosis and interstitial fibrosis (9, 10).   
To our knowledge, no studies have investigated the effects of MR on kidney insulin sensitivity and we 
hypothesised that MR dietary intervention may be a viable measure for protecting against renal 
dysfunction as a consequence of age-related glucose intolerance by improving renal insulin signalling.  
To provide proof-of-principle data for further human intervention studies, we used aged mice to test 
this hypothesis. 
 
 
 
 
 
 
 
 
 
 
 
2. Materials and Methods 
2.1 Animal studies. 
All animal procedures were approved by the University of Aberdeen Ethics Review Board and 
performed under UK Home Office project license PPL60/3951 and according to the ARRIVE 
guidelines.  Ten-month old male and female C57BL/6J wild-type mice (Charles River, Edinburgh, 
UK) were singly housed and maintained at 22-24ºC on 12-hour light/dark cycle with free access to 
food/water.  Mice were maintained on a control diet (0.86% methionine) (Dyets, Bethlehem, PA, 
USA) for two weeks.  They were then randomised into two groups based on body weight with one 
group given control diet and the other given MR diet containing 0.172% methionine (Dyets, 
Bethlehem, PA, USA), as described previously (7).  The mice were maintained on each diet for 8 
weeks and terminal tissues harvested after 5 hour fasting.  For insulin signalling experiments, male 
mice only were investigated.  Intraperitoneal (i.p.) injection with saline (154 mM NaCl) or insulin (10 
mU/g body weight) was administered after 5 hour fast, and mice sacrificed by cervical dislocation 
after 10 min.  Kidneys were harvested and frozen immediately in liquid nitrogen.  For histological 
analysis, 8-week old male C57BL/6J wild-type mice were randomised  to MR or control dietbased on 
body weight, for 190  days before kidneys were harvested and fixed in ethanol and stored at 4°C 
before wax embedding and sectioning. Body composition for long-term experiment was measured by 
NMR using a Bruker Minispec (Billerica, MA). 
 
 
2.2 Blood metabolites and whole body measurements. 
Tail vein blood samples were obtained after a 5 hour fast and blood glucose measurements taken using 
glucometers (AlphaTRAK, Berkshire, UK), 6 weeks after the initiation of the diets.  For the long-term 
MR diet study, tail vein blood samples were obtained after a 5 hour fast and serum insulin levels were 
measured by ELISA as per the manufacturer’s instructions (EMD Millipore,Temecula, CA). 
 
2.3 Immunoblotting 
Frozen kidney lysates were prepared in radioimmunoprecipitation-assay (RIPA) buffer containing fresh 
sodium-orthovanadate and protease-inhibitors (11).  Proteins were separated by 4-12% SDS-PAGE and 
transferred to nitrocellulose membranes. Immunoblots were performed using antibodies from Cell 
Signaling (NEB, Hitchin, UK) (unless stated otherwise) against phospho-Akt/PKB (s473), total 
Akt/PKB A2210 (Santa Cruz, Dallas, TX, USA), phospho-S6 ribosomal protein (s235/236), total S6 
2217S, phospho-IR (tyr1162/1163) 44804G (Invitrogen, Paisley, UK), phospho-IR (tyr1158), IR-βsc-
711 (Santa-Cruz, Dallas, TX, USA), β-actin (Thermo Scientific, Waltham, USA), cytochrome C, 
mitochondrial transcription factor (TFAM), PGC1α (Abcam, Cambridge, UK), UCP1 (Abcam, 
Cambridge, UK) . Immunoblots were visualized using enhanced-chemiluminescence, and quantified by 
densitometry scanning using Bio1D-software (PeqLab, Fareham, UK).  
 
2.4 Gene-expression analysis.  
Frozen kidney sections were homogenized in TriFast reagent (Peqlab, UK) (20). cDNA synthesis was 
carried out from 1 µg of RNA using Tetro cDNA-synthesis kit (Bioline, London, UK).  Target genes 
were amplified by quantitative real-time PCR using gene-specific primers (Sigma, UK) and GoTaq 
master mix (Promega, Southampton, UK) using the Light-Cycler 480 (Roche).  Relative mRNA levels 
were calculated using the Pfaffl method (12) and normalised to the most stable reference gene (YWhaz, 
NoNo, GAPDH, HPRT or β-actin) which was identified using a web-based reference gene assessment 
tool (http://www.leonxie.com/referencegene.php?type=reference). Primer sequences are provided in 
supplementary material.  
 
2.5 Histological analysis 
Kidney tissue was fixed in formaldehyde, embedded in paraffin, sectioned at 5μm, and stained with 
haematoxylin and eosin.  Slides were scored using a graticule at x20 magnification by Dr Paul AJ 
Brown, consultant pathologist, Aberdeen Royal Infirmary, who was blinded to the study.  100 random 
intersections were examined for each kidney and a score of 0 or 1 was given for each tubular profile 
involving an intersection: 0 = normal histology; 1 = vacuole(s) involving that tubular profile.  The total 
score for each kidney was calculated by addition of all 100 scores with a maximum score of 100.   
 
2.6 Statistical analysis.  
Data are expressed as mean ± SEM. Statistical analyses were performed using one-way ANOVA with 
Tukey’s multiple comparison post-tests, two-way ANOVA with Bonferroni-multiple comparisons post-
tests, and two-tailed Student’s t-tests, as appropriate, using GraphPad Prism 5 statistical-software 
(GraphPad Sortware Inc., San Diego, CA, USA).  P-values < 0.05 were considered significant. 
 
 
 
 
 
3. Results 
3.1 MR diet decreases fasting glucose levels, improves glucose tolerance and enhances renal 
insulin signalling 
Eight weeks of dietary MR produced significant decreases in fasting blood glucose levels in both male 
and female mice when compared to control littermates (fig. 1A). Glucose tolerance testing (GTT) 
revealed an improvement in glucose tolerance in MR-diet fed male mice compared to controls (fig 1B), 
in both males and females, as represented by Area Under the Curve (AUC). To test the impact of dietary 
MR on insulin signalling in the kidney, renal tissue (medulla and cortex) was harvested from male mice 
after a 5 h fast and acute injection with insulin (10mU/g body weight) (fig 1C).  Following insulin 
binding, a number of tyrosine residues including tyrosines 1158, 1162, and 1163 on the insulin receptor 
(IR) become autophosphorylated, leading to the phosphorylation of target substrates including IRS 
proteins (13).  The phosphorylation of PKB/Akt also activates mTORC1 leading to increased protein 
synthesis, via activation of S6K1 and its target S6 (14)  Diet-induced increases in insulin-dependent 
PKB/Akt and S6 phosphorylation were observed with no effect on insulin activation of its receptor, 
suggesting that MR amplifies insulin signal downstream of IR, at the level of PKB/Akt (fig 1C and 1D).  
The enhancement of insulin-induced phosphorylation of PKB/Akt and S6 by dietary MR, in conjunction 
with diet-induced reductions in fasting glucose, are consistent with both global and tissue-specific 
effects of dietary MR on insulin sensitivity. 
 
3.2 MR diet increases lipogenic gene expression in the kidney 
In view of the improved glucose homeostasis and enhanced diet-dependent insulin signalling observed 
in the MR-diet mice, we investigated diet-dependent effects on lipid metabolism in the kidney, where 
it was hypothesised that a more insulin sensitive state would be reflected in increased lipogenesis and 
inhibition of gluconeogenesis.   
Insulin promotes de novo lipogenesis (DNL) by activating the lipogenic transcription factor sterol 
regulatory element-binding protein 1c (SREBP1c).  For example, acetyl-CoA carboxylase (ACC) and 
fatty acid synthase (FAS) regulate key steps in fatty acid biosynthesis and both are regulated by 
SREBP1c (15).  Most notably in females, dietary MR increased renal expression of FAS, SREBP1c, and 
the ACC1 and ACC2 isoforms of ACC (fig 2A).  A similar pattern was found in the MR-fed male mice, 
but only the increase in ACC2 expression reached significance, in addition to another promoter of 
lipogenesis, peroxisome proliferator-activated-receptor gamma (PPARγ) (fig 2B).  Dietary MR in 
female mice led to suppressed expression of the gluconeogenic gene, phosphoenolpyruvate 
carboxykinase (PEPCK) in kidneys compared to controls (fig 2A).   
 
3.3 MR diet upregulates UCP1 and renoprotective gene expression 
Methionine restriction significantly upregulated renal expression of fibroblast growth factor (FGF21), 
Klotho and β-Klotho mRNA in females, and Sirtuin 1 (Sirt1) mRNA expression in male kidneys (fig 
3A and 3B); all of which possess renoprotective properties (16-18).   
Dietary MR was previously shown to increase expression of adipose uncoupling protein-1 (UCP1) (19).  
To our knowledge, little is known about the function or even the expression of uncoupling protein 1 
(UCP1) in mouse kidney.  In this study we observed abundant expression of renal UCP1 which was 
significantly elevated in the female MR group compared to control.  Protein levels of UCP1, however, 
were variable between subjects and no significant differences were observed between treatment groups 
in females and males (fig A and B, respectively).  This was also the case for other proteins involved in 
mitochondrial biogenesis (proliferator-activated receptor γ coactivator 1; PGC1α, transcription factor 
A, TFAM, and cytochrome C) (fig A and 4B). 
 
3.4 Renal pro-inflammatory gene expression is not upregulated by MR diet 
The presence of chronic low-grade inflammation is a hallmark of numerous age-related conditions 
including the decline in renal function that is observed with increasing age (20, 21).  It was therefore of 
interest to determine gene expression levels of a panel of pro-inflammatory and anti-inflammatory 
markers in aged kidneys from mice fed MR and control diet.  Renal expression of the pro-inflammatory 
mediators tumour necrosis factor-alpha (TNFα), interleukin-6 (IL-6), interleukin-1-beta  (IL-1β), and 
monocyte chemoattractant protein-1 (MCP-1) and markers of macrophage accumulation the 
macrophage F4/80 receptor (F4/80), cluster of differentiation molecule-11b (CD11b), and cluster of 
differentiation molecule-68 (CD68) in female and male MR groups were unchanged when compared to 
control mice (fig 5A and 5B, respectively).  The pro-fibrotic mediators, platelet derived growth factor-
B (PDGF-B) and transforming growth factor-beta (TGF-β) were also unaltered by MR diet. (fig 5A).    
 
3.5 Long-term MR diet decreases body weight, fat mass and serum insulin levels 
As expected, long-term (190 day) MR diet significantly decreased body weight (as measured in the 
final 3 weeks of the study) compared to control diet (fig 6A).  A significant decrease in lean mass (g) 
was observed in MR-fed mice (fig 6B) but when calculated as a percentage of total body weight, lean 
mass was found to be significantly increased by MR diet compared to control diet (fig 6C).  Methionine 
restriction significantly decreased total body fat (fig 6D) and percentage body fat (fig 6E) compared to 
control diet fed mice.  Fasting insulin levels were also found to be significantly decreased by long-term 
MR feeding (fig 6F). 
 3.6 Long-term MR diet offers some protection against renal damage 
With increasing age, the kidney is less effective at concentrating or diluting urine and more likely to 
retain salt, and these dysfunctions are associated with age-associated histological changes (8).  In order 
to investigate the effect of MR diet on the ageing kidney, renal histology was assessed in mice which 
had been fed the MR or control diet for a prolonged period of 190 days. It was observed that there was 
an non-significant increase in vacuoles within the proximal convoluted tubules in control aged kidneys, 
whilst MR-fed kidneys offered a degree of protection, as determined by H and E staining (fig 7  A, B, 
C).  This did not appear to correlate to body weight or serum insulin levels measured in these mice ((fig 
7 D, E).   
 
 
 
 
 
 
 
 
  
4. Discussion  
Dietary MR offers promise as an intervention for the treatment of metabolic dysfunction due to its 
ability to reduce body weight and adiposity, despite an increase in food intake (5, 19).  Moreover, dietary 
MR improves insulin sensitivity and glucose/lipid homeostasis in rodents and humans (7, 19, 22, 23).  
Kidney function is known to decline with age and is exacerbated by an age-related occurrence of 
increased insulin resistance, inflammation, and oxidative stress (8).  With regard to dietary 
modifications, caloric restriction (CR) has proven to be the most efficacious mode of protecting against 
the onset of age-related kidney damage in rodent models (24).  In this study we sought to elucidate the 
effect of dietary MR, which unlike CR permits ad libitum feeding, on whole body glucose homeostasis, 
renal insulin signalling, lipogenic and inflammatory gene expression, and histology in aged mice.   
Following 8 weeks on MR diet, mice had significantly improved glucose tolerance, and lower fasting 
blood glucose levels than controls indicative of improved glucose homeostasis, as reported previously 
(7).  In addition, levels of insulin-stimulated phosphorylated proteins within the insulin signalling 
cascade (PKB/Akt and S6) were significantly greater in kidneys of mice fed a MR diet compared to 
controls.  The tissue-specific enhancement of insulin signalling by MR is in agreement with similar 
studies looking at white adipose tissue (WAT), liver and muscle and reinforces the potential application 
of MR diet as a protective dietary intervention against age-associated metabolic dysfunction (7).  
Interestingly, a recent paper demonstrated that very low protein diet ameliorates advanced diabetic 
nephropathy (35), associated with suppression of p-S6 ribosomal protein (p-S6RP), which is in line 
with the data presented in this manuscript.  We also observed upregulation of genes involved in 
lipogenesis and suppressed expression of the gluconeogenic gene, PEPCK in the kidney of MR mice 
compared to controls inferring improved insulin responsiveness.  A similar upregulation in lipogenic 
genes has been observed in white adipose tissue from MR diet-fed mice with a concomitant decrease in 
hepatic lipogenic gene expression, and it is believed that this metabolic remodelling may lead to 
improved insulin sensitivity (7, 25).  
It has been postulated that the loss of adiposity despite increased consumption of a MR diet is due, at 
least in part, to elevated energy expenditure driven by UCP-1 nonshivering thermogenesis in adipose 
tissue (19) and MR has recently been shown to greatly upregulate UCP-1 expressing cells in inguinal 
WAT leading to increased respiratory capacity (26).  However, the function of UCP1 in the kidney is 
not known. Conflicting reports have been published on the presence of UCP-1 in the rodent kidney (27, 
28), however our data clearly shows that UCP-1 is highly expressed at the mRNA level and, albeit with 
high variability between replicates, at the protein level too.  We observed substantial upregulation, most 
notably in the females, of renal UCP-1 gene expression in MR mice compared to controls.  Although 
at the protein level, a MR diet was found to exert no effect on levels of UCP-1 and other mitochondrial 
biogenesis markers, the significant increase in renal UCP-1 gene expression is of interest and worthy 
of future investigation.  The notable sexual dimorphism apparent for the gene expression profiles, 
whereby female mice exhibited greater dietary-induced changes than males, is also of significance.  
Substantial evidence exists to suggest that male kidneys are more vulnerable to age-related decline in 
renal function than females (20, 24, 29, 30).  
Our group has recently demonstrated that short-term MR treatment (48 hr) is sufficient to significantly 
increase circulating levels and hepatic expression of FGF21 in mice (7).  This was associated with 
improvements in insulin sensitivity, independent of changes in body composition or weight.  Similarly, 
in this study we observed an upregulation of renal FGF21 mRNA in MR-fed mice compared to controls 
which may contribute to the insulin-sensitizing effects observed in the kidneys of these animals.  FGF21 
is a hormone released by the liver in response to caloric restriction and markedly extends the lifespan 
of mice when overexpressed (31).  The kidney has been identified as a target of FGF21, and exogenous 
administration of FGF21 protein has been shown to improve systemic metabolism and exert anti-
fibrotic properties in kidneys of db/db mice (16).  More recently, it has been demonstrated that 
upregulation of renal FGF21 expression in streptozotocin-treated C57/BL mice leads to a significant 
renal protection, believed to be due to PI3K/Akt/GSK3β/Fyn-mediated activation of the Nrf2 anti-
oxidative pathway (32).  In this study we identified significant upregulation of renal FGF21 mRNA in 
MR-fed females, in addition to increased expression of the FGF21 co-receptor, β-Klotho.  Klotho which 
is highly expressed in the kidney, was also significantly upregulated by a MR diet and has been deemed 
of therapeutic interest due to the observation that klotho deficiency is associated with increased 
susceptibility to injury and fibrosis with prolonged kidney recovery (33).  Sirt-1, which also exerts 
renoprotective effects and regulates lipid and glucose metabolism, has been identified as another 
therapeutic target for renal diseases (18), and was found to be elevated at the mRNA level in kidneys 
from MR-fed male mice.  Taken together, these gene expression alterations associated with the adoption 
of dietary MR, may reduce the decline in renal function that is associated with ageing. 
Chronic low-grade inflammation is known to play a role in the degenerative processes associated with 
the ageing kidney (20, 21).  In this study, renal gene expression of pro-inflammatory cytokines or pro-
fibrotic mediators were reassuringly unaltered by MR diet.  Interestingly, levels of anti-inflammatory 
genes IL-10 and IL-4, showed the biggest increase in kidneys from MR diet-fed animals compared to 
control suggesting a potential protective effect by MR.  Histological evidence of chronic renal damage 
was not observed in these animals, but there was evidence of tubular injury.  There was a trend towards 
increased presence of proximal tubule vacuoles in control aged kidneys compared to those from mice 
on long-term MR diet, which was not due to decreased body weight/adiposity or serum insulin (34).  
The underlying cause of this histological damage is uncertain and requires further study.   
These data suggest that dietary manipulation by MR in mice enhances renal insulin signalling and 
increases expression of genes involved in lipogenesis, thermogenesis and renoprotection without 
affecting levels of pro-inflammatory mediators in aged mice.  Since the ageing kidney can display a 
number of non-specific changes that have similarities to those observed in diabetic nephropathy (DN), 
positive findings may be of therapeutic value to this condition too. It would be of merit to use mouse 
models of DN to assess whether MR dietary intervention is able to delay, prevent or reverse the fibrotic 
and pro-inflammatory phenotype observed in these models.  Positive findings may translate into a new 
therapeutic dietary intervention for DN and other disorders associated with metabolic dysfunction. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure legends 
Figure 1.  Blood glucose levels, glucose tolerance and renal insulin signalling of mice on a methionine 
restriction (MR) and control diet.  (A) Mice fed a MR-diet (n = 10 for males and n = 7 for females) for 
8 weeks had significantly lower blood glucose levels than their control diet counterparts (n = 9 for males 
and n = 7 for females). Significance was calculated by 2–tailed Student’s t-test.  Data are represented 
as mean ± SEM.  White bars represent control-fed mice and black bars represent MR-fed mice.  (B) 
Glucose tolerance testing (2g/kg glucose dose) was carried out after 6 weeks on diets after a 5-h fast in 
male mice and female mice and data was expressed as area under the curve.  Significance was calculated 
by r 2-tailed Student’s t-tests.  (C) Insulin signalling was measured by administering saline (n = 3) or 
insulin (10 mU/g of body weight; n = 5) to male mice i.p. after a 5-h fast (*P<0.05).  Mice were 
sacrificed 10 min after injection and tissues harvested for analysis.  Levels of phosphorylated IR 
(tyr1162/1163 and tyr1158), Akt (ser473), S6 (ser235/236), IR-β, total Akt, total S6, and β-actin were 
determined by immunoblotting (C) and normalised to total proteins. (D)  Data were analysed as fold 
change relative to control-fed insulin-injected mice.  Significance was calculated by two-tailed 
Student’s t-test (*P<0.05) (D).  Data are represented as mean ± SEM.  Checked bars represent control 
(saline) mice, white bars represent control (insulin) mice, striped bars represent MR (saline) mice, and 
black bars represent MR (insulin) mice. 
 
Figure 2. Renal expression of genes pertinent to lipid and glucose metabolism in mice fed control or 
methionine restriction (MR) diet for 8 weeks in (A) female mice (n = 6 – 8) and (B) male mice (n = 7 
– 10) as determined by qPCR.  Data were analysed as fold change relative to control-fed mice.  
Significance was calculated by two-tailed Student’s t-test (*P<0.05).  Data are represented as mean ± 
SEM.  White bars represent control-fed mice and black bars represent MR-fed mice. 
 
Figure 3. Renal expression of genes pertinent to mitochondrial biogenesis and renoprotection in mice 
fed control or methionine restriction (MR) diet for 8 weeks in (A) female mice (n = 6 – 8) and (B) male 
mice (n = 7 – 10) as determined by qPCR.  Data were analysed as fold change relative to control-fed 
mice.  Significance was calculated by two-tailed Student’s t-test (*P<0.05).  Data are represented as 
mean ± SEM.  White bars represent control-fed mice and black bars represent MR-fed mice. 
 
Figure 4.  Levels of mitochondrial biogenesis markers present in kidneys from mice fed control or 
methionine restriction (MR) diet for 8 weeks.  Protein levels of PGC1α, UCP1, TFAM and cytochrome 
C were determined by immunoblotting for (A) female, and (B) male mice, and normalised to β-actin.  
Data were analysed as fold change relative to control mice.  Significance was calculated by two-tailed 
Student’s t-test (*P<0.05).  Data are represented as mean ± SEM.  White bars represent control-fed 
mice and black bars represent MR-fed mice. 
 Figure 5. Pro-inflammatory and anti-inflammatory gene expression in kidneys from mice fed control or 
methionine restriction (MR) diet for 8 weeks.  Gene expression was measured by qPCR in kidneys from 
(A) female mice (n = 6 – 8) and (B) male mice (n = 7 – 10) fed control or MR diet.  Data were analysed 
as fold change relative to control-fed mice.  Significance was calculated by two-tailed Student’s t-test 
(*P<0.05).  Data are represented as mean ± SEM.  White bars represent control-fed mice and black bars 
represent MR-fed mice. 
 
Figure 6. Body weight, composition, and serum insulin levels of male mice on long-term (190 days) 
MR diet (n = 7) compared to control diet (n = 8).  (A) Body weight measurements taken over 190 days 
on MR diet or control diet.  (B) Lean mass (g), (C) lean mass as a percentage of total body mass, (D) 
fat mass (g), and (E) fat mass as a percentage of total body mass were measured using NMR in mice 
fed MR diet or control diet.  (F) Fasted serum insulin levels (ng/ml) measured following 190 days of 
MR diet or control diet.  Significance was calculated by repeated measures two-way ANOVA with 
Bonferroni multiple comparison post hoc tests or 2-tailed Student’s t-tests. Data are represented as mean 
± SEM. White circles/bars represent control-fed mice and black circles/bars represent MR-fed mice. 
 
Figure 7.  Representative images of H and E stains obtained for kidney sections from a mouse that had 
been on long-term (190  days) MR diet showing (A) large vacuoles in a proximal renal tubule with 
normal renal tubules surrounding the one affected tubule and (B) large vacuoles present in 2 proximal 
tubules.  (C) Bar chart showing scores, representing the number of tubule intersections containing 
vacuoles, obtained for individual mice within each treatment group.  Correlation between the number 
of tubule intersections containing vacuoles and (D) body weight and (E) insulin levels for each 
individual mouse.   
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Supplementary Material 
 
Primer sequences 
 
ACC1 F  GATGAACCATCTCCGTTGGC 
ACC1 R  GACCCAATTATGAATCGGAGTG 
 ACC2 F  CGCTCACCAACAGTAAGGTGG 
ACC2 R  GCTTGGCAGGGAGTTCCTC 
 
Arginase F  CAGAAGAATGGAAGAGTCAG 
Arginase R  CAGATATGCAGGGAGTCACC 
 
β-actin F  GATCTGGCACCACACACCTTC 
β-actin R  GGGGTGTTGAAGGTCTCAAA 
 
CD11b F  CCCCACACTAGCATCAAGG 
CD11b R  GAGGCAAGGGACACACTGA 
 
CD68 F   TGTCTGATCTTGCTAGGACCA 
CD68 R  GAGAGTAACGGCCTTTTTGTGA 
 
F4/80 F   CCCAGCTTATGCCACCTGCA 
F4/80 R  GTCCAGGCCCTGGAACATTGG 
 
FAS F   GGAGGTGGTGATAGCCGGTAT  
FAS R   TGGGTAATCCATAGAGCCCAG 
 
G6Pase F  ATGAACATTCTCCATGACTTTGGG 
G6Pase R  GACAGGGAACTGCTTTATTATAGG 
 
GAPDH F  TGACCACAGTCCATGCCATC 
GAPDH R  GACGGACACATTGGGGGTA 
 
 
HPRT F  GTTAAGCAGTACAGCCCCAAA 
HPRT R  AGGGCATATCCAACAACAAACTT 
 
IL1 beta F  GCAACTGTTCCTGAACTCAACT 
IL1 beta R  ATCTTTTGGGGTCCGTCAACT 
 IL4 F   GGTCTCAACCCCCAGCTAGT 
IL4 R   GCCGATGATCTCTCTCAAGTGAT 
 
IL4RA F  TCTGCATCCCGTTGTTTTGC 
IL4RA R  GCACCTGTGCATCCTGAATG 
 
IL6 F   TAGTCCTTCCTACCCCAATTTCC 
IL6 R   TTGGTCCTTAGCCACTCCTTC 
 
IL10 F   GCTCTTACTGACTGGCATGAG 
IL10 R   CGCAGCTCTAGGAGCATGTG 
 
Klotho F  GGGACACTTTCACCCATCACT 
Klotho R  ACGTTGTTGTAACTATCGCTGG 
 
βKlotho F  TGTTCTGCTGCGAGCTGTTAC 
βKlotho R  CCGGACTCACGTACTGTTTTT 
 
MCP-1 F  TTAAAAACCTGGATCGGAACCAA 
MCP-1 R  GCATTAGCTTCAGATTTACGGGT 
 
NoNo F  GCCAGAATGAAGGCTTGACTAT 
NoNo R  TATCAGGGGGAAGATTGCCCA 
 
PDGF-B F  CATCCGCTCCTTTGATGATCTT 
PDGF-B R  GTGCTCGGGTCATGTTCAAGT 
 
PEPCK F  GAGATAGCGGCACAAT 
PEPCK R  TTCAGAGACTATGCGGTG 
 
PGC1α F  AACCACACCCACAGGATCAGA 
PGC1α R  TCTTCGCTTTATTGCTCCATGA 
 PPARγ F  AGTGGAGACCGCCCAGG 
PPARγ R  GTAGCAGGTTGTCTTGAATGT 
 
SCD1 F  TTCTTGCGATACACTCTGGTGC 
SCD1 R  CGGGATTGAATGTTCTTGTCGT 
 
Sirt1 F   TGATTGGCACAGATCCTCG 
Sirt1 R   CCACAGTGTCATATCATCCAA 
 
SREBP1 F  ATGTGCGAACTGGACACAGCG 
SREBP1 R  AGGCTGTAGGATGGTGAGTGG 
 
SREBP2 F  CCCTTGACTTCCTTGCTGCA 
SREBP2 R  GCGTGAGTGTGGGCGAATC 
 
TFAM F  ATTCCGAAGTGTTTTTCCAGCA 
TFAM R  TCTGAAAGTTTTGCATCTGGGT 
 
TGFβ F  AGCCCGAAGCGGACTACTAT 
TGFβ R  CTGTGTGAGATGTCTTTGGTTTTC 
 
TNF-alpha F  CCCTCACACTCAGATCATCTTCT 
TNF-alpha R  GCTACGACGTGGGCTACAG 
 
UCP1 F  AGGCTTCCAGTACCATTAGGT 
UCP1 R  CTGAGTGAGGCAAAGCTGATTT 
UCP2 F  ATGGTTGGTTTCAAGGCCACA 
UCP2 R  CGGTATCCAGAGGGAAAGTGAT 
 
YWhaz F  GAAAAGTTCTTGATCCCCAATGC 
YWhaz R  TGTGACTGGTCCACAATTCCTT 
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